Skip to main content

Advertisement

Table 2 Muscle activation pattern (%MVC) during SLR neurodynamic testing

From: Mechanosensitivity during lower extremity neurodynamic testing is diminished in individuals with Type 2 Diabetes Mellitus and peripheral neuropathy: a cross sectional study

   PF/SLR DF/SLR
Muscle Resting Start P1 P2 Start P1 P2
Soleus 20.2 ± 16.1 19.9 ± 15.7 21.3 ± 16.6† 21.7 ± 16.3 20.7 ± 17.4 23.0 ± 19.5† 22.6 ± 16.7
Medial gastrocnemius 14.6 ± 13.6 16.0 ± 15.2 18.9 ± 19.3 20.2 ± 21.5 16.8 ± 16.2 19.4 ± 20.77 19.9 ± 18.0
Tibialis anterior 5.3 ± 4.1 5.2 ± 4.3† 5.7 ± 5.5† 6.3 ± 6.9† 9.7 ± 8.9 *† 9.0 ± 8.0 *† 9.4 ± 10.1 *†
Vastus medialis 13.8 ± 12.2 13.9 ± 12.9† 16.3 ± 14.9 16.5 ± 14.0 9.9 ± 7.6† 15.7 ± 14.1 15.6 ± 12.9
Rectus femoris 11.8 ± 7.8 12.4 ± 10.1 14.8 ± 14.7 15.9 ± 13.1† 12.6 ± 9.7 13.4 ± 9.9 14.2 ± 9.6†
Semitendinosus 9.3 ± 8.3 9.7 ± 9.0 10.6 ± 9.0 12.4 ± 9.1 9.6 ± 9.5 11.3 ± 9.5 12.7 ± 9.9
Biceps femoris 9.3 ± 6.1 10.4 ± 7.1† 11.2 ± 7.9 13.5 ± 8.8 9.1 ± 6.3† 13.3 ± 17.4 13.4 ± 9.4
Gluteus maximus 28.4 ± 21.0 28.2 ± 23.3 31.6 ± 26.9 36.0 ± 29.2 28.8 ± 22.6 34.8 ± 43.8 38.9 ± 36.1
  1. * denotes statistically significant increase of greater than 1.5x "Resting" levels for general linear model of repeated measures for within test differences.
  2. † denotes statistically significant difference between PF/SLR and DF/SLR tests using paired t-test comparison for "Start" and "P1" and "P2."